X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (81) 81
index medicus (77) 77
female (71) 71
male (65) 65
middle aged (63) 63
aged (60) 60
adult (52) 52
oncology (43) 43
hematology (41) 41
aged, 80 and over (34) 34
survival (34) 34
prognosis (24) 24
rituximab (24) 24
antineoplastic combined chemotherapy protocols - therapeutic use (23) 23
chemotherapy (23) 23
retrospective studies (23) 23
treatment outcome (22) 22
adolescent (20) 20
young adult (20) 20
cancer (17) 17
follow-up studies (17) 17
disease-free survival (16) 16
analysis (15) 15
antineoplastic combined chemotherapy protocols - administration & dosage (14) 14
neoplasm staging (14) 14
follicular lymphoma (13) 13
kaplan-meier estimate (13) 13
antineoplastic combined chemotherapy protocols - adverse effects (12) 12
care and treatment (12) 12
diagnosis (12) 12
disease (12) 12
risk factors (12) 12
survival analysis (12) 12
italy (11) 11
survival rate (11) 11
doxorubicin - administration & dosage (10) 10
lymphoma, follicular - drug therapy (10) 10
lymphomas (10) 10
non-hodgkins-lymphoma (10) 10
risk (10) 10
cyclophosphamide - administration & dosage (9) 9
incidence (9) 9
lymphoma (9) 9
proportional hazards models (9) 9
therapy (9) 9
cyclophosphamide (8) 8
expression (8) 8
italy - epidemiology (8) 8
non-hodgkin lymphoma (8) 8
non-hodgkin's lymphomas (8) 8
prednisone - administration & dosage (8) 8
registries (8) 8
research (8) 8
time factors (8) 8
trial (8) 8
vincristine - administration & dosage (8) 8
apoptosis (7) 7
breast cancer (7) 7
chop (7) 7
combination (7) 7
hodgkin disease - drug therapy (7) 7
internal medicine (7) 7
lymphoma, follicular - mortality (7) 7
lymphoma, follicular - pathology (7) 7
medicine & public health (7) 7
multivariate analysis (7) 7
non-hodgkins-lymphomas (7) 7
outcomes (7) 7
peripheral vascular disease (7) 7
surgery (7) 7
b-cell lymphoma (6) 6
bleomycin - administration & dosage (6) 6
fludarabine (6) 6
hodgkin disease - mortality (6) 6
lenalidomide (6) 6
medicine, general & internal (6) 6
positron-emission-tomography (6) 6
prospective studies (6) 6
radiotherapy (6) 6
response criteria (6) 6
vidarabine - administration & dosage (6) 6
vidarabine - analogs & derivatives (6) 6
abridged index medicus (5) 5
anemia - chemically induced (5) 5
antineoplastic agents - therapeutic use (5) 5
cell line, tumor (5) 5
child (5) 5
child, preschool (5) 5
cohort (5) 5
combined modality therapy (5) 5
dacarbazine - administration & dosage (5) 5
disease progression (5) 5
doxorubicin (5) 5
hodgkin disease - pathology (5) 5
leukocyte count (5) 5
lymphoma, large b-cell, diffuse - mortality (5) 5
metaanalysis (5) 5
multiple-myeloma (5) 5
patient outcomes (5) 5
recurrence (5) 5
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 09/2009, Volume 27, Issue 27, pp. 4555 - 4562
Purpose The aim of the F2 study was to verify whether a prospective collection of data would enable the development of a more accurate prognostic index for... 
SURVIVAL | TRIAL | LOW-GRADE LYMPHOMA | RESPONSE CRITERIA | ONCOLOGY | RITUXIMAB | SERUM BETA-2-MICROGLOBULIN | NON-HODGKINS-LYMPHOMA | MODEL | MULTIVARIATE-ANALYSIS | PREDICTION
Journal Article
Journal Article
Apoptosis, ISSN 1360-8185, 06/2017, Volume 22, Issue 6, pp. 827 - 840
Histone deacetylase inhibitors (HDACis) have emerged as a new class of anticancer agents, targeting the biological process including cell cycle and apoptosis.... 
Bendamustine | Synergistic effect | Lymphoma | Ricolinostat | Apoptosis | MULTIPLE-MYELOMA | MULTICENTER | AGGRESOME FORMATION | ACY-1215 | ACETYLATION | BIOCHEMISTRY & MOLECULAR BIOLOGY | MECHANISMS | CELL BIOLOGY | THIOREDOXIN | IN-VIVO | LENALIDOMIDE | HISTONE DEACETYLASE INHIBITORS | Bendamustine Hydrochloride - therapeutic use | Reactive Oxygen Species - metabolism | Apoptosis - drug effects | Humans | Lymphoma, Non-Hodgkin - pathology | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Histone Deacetylase 6 - metabolism | Lymphoma - drug therapy | Mesenchymal Stromal Cells - cytology | Microtubules - metabolism | Tubulin - metabolism | Caspases - metabolism | Microtubules - drug effects | Interleukin-10 - metabolism | Lymphoma - pathology | Clone Cells | Proto-Oncogene Proteins c-akt - metabolism | Hydroxamic Acids - pharmacology | Lymphoma, Non-Hodgkin - drug therapy | Cell Survival - drug effects | Mesenchymal Stromal Cells - drug effects | Endoplasmic Reticulum Stress - drug effects | Histone Deacetylase 6 - antagonists & inhibitors | Cell Cycle Proteins - metabolism | Pyrimidines - pharmacology | Enzyme Activation - drug effects | Drug Synergism | Acetylation - drug effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Pyrimidines - therapeutic use | Bendamustine Hydrochloride - pharmacology | Cell Line, Tumor | Histone Deacetylase Inhibitors - pharmacology | Hydroxamic Acids - therapeutic use | Cell Proliferation - drug effects | Histone Deacetylase Inhibitors - therapeutic use | Proto-Oncogene Proteins c-bcl-2 | Cell Cycle - drug effects
Journal Article
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 12/2014, Volume 20, Issue 24, pp. 6398 - 6405
Journal Article
Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 21, pp. 3124 - 3124
Abstract Background and Purpose. Histone deacetylase (HDAC) inhibitors are emerging as an exciting new therapeutic option for lymphoid malignancies.... 
Journal Article
Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 21, pp. 3088 - 3088
Abstract active and well tolerated single agent in the treatment of heavily pretreated Hodgkin lymphoma patients. In this pilot phase II study patients with... 
Journal Article
British Journal of Haematology, ISSN 0007-1048, 06/2018, Volume 181, Issue 6, pp. 760 - 769
Journal Article